Delivery Order SPE2DR25D2007-SPE2DR26FM13B
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,537.96 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count) with an ultimate completion date of October 22, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $11,752.69 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (500-count units) with an ultimate completion date of June 2, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a competitive award under the company's larger pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,110.41 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (500 count) on August 14, 2025, with ultimate completion scheduled for August 15, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform this work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,566.01 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count packaging) under a firm fixed price contract. The award was issued on September 19, 2025, with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Ondansetron HCL 4 mg tablets (30-count packaging) with a contract value of $3,436.96. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract has an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order valued at $1,328.71 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30 count) under a firm fixed-price contract. This award, announced on October 23, 2025, with an ultimate completion date of October 24, 2025, was made without a set-aside designation through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,030.04 to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Ondansetron HCL 4 mg tablets (500-count units). This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025. This delivery order is...
- The Defense Logistics Agency awarded a $41,606.24 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with an ultimate completion date of November 17, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement for pharmaceutical products supporting federal medical supply needs. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,759.95 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets in quantities of 30, with an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be performed from the contractor's facility...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) valued at $11,571.36 under a firm fixed-price contract. The award was made on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement to support federal medical supply needs, with performance to occur at AmerisourceBergen's corporate office location in...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM13BDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $41,236.32 for the supply of Ondansetron HCL 4 mg tablets (500-count units) with a completion date of November 17, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating it was competitively awarded through open competition. Performance will be executed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle supports comprehensive pharmaceutical and medical supply requirements for military healthcare systems globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The delivery order aligns with AmerisourceBergen's established role as a critical federal pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contracting mechanisms designed to support ongoing military medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.2k | 11/14/25 |